We are live on ! Find out more
NEUE

NeueHealth

Delisted

NEUE was delisted on the 1st of October, 2025.

36 hedge funds and large institutions have $27.1M invested in NeueHealth in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

0.13% less ownership

Funds ownership: 62.94%62.81% (-0.13%)

4% less capital invested

Capital invested by funds: $28.2M → $27.1M (-$1.03M)

12% less funds holding

Funds holding: 4136 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
36
Holders Change
-5
Holders Change %
-12.2%
% of All Funds
0.52%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
2
Increased
7
Reduced
5
Closed
7
Calls
Puts
Net Calls
Net Calls Change

NEUE Hedge Fund Activity: Q3 2024 in Review

36 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in NeueHealth (NEUE) for Q3 2024, worth a combined $27.1M — down 3.7% from $28.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NEUE and 2 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Partners Group Holding, adding an estimated $72.9K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.3K sold.

  • 36 institutional investors held NeueHealth (NEUE) as of Q3 2024, down from 41 in Q2 2024.
  • Funds reported $27.1M of NeueHealth stock for Q3 2024, down 3.7% quarter-over-quarter.
  • 2 funds opened new NeueHealth positions in Q3 2024 and 7 closed out, a net change of -5 holders.
  • The largest NeueHealth buyer in Q3 2024 was Partners Group Holding, an estimated $72.9K added.
  • The largest NeueHealth seller in Q3 2024 was Tower Research Capital (TRC), an estimated $5.3K sold.

Based on aggregated 13F filings for Q3 2024.